ADJUVANT HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE WITH G-CSF SUPPORT IN PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER

被引：0
|
作者：
KONECNY, G [1 ]
UNTCH, M [1 ]
BAUERFEIND, I [1 ]
PICHE, E [1 ]
NESTLEKRAMLING, C [1 ]
机构：
[1] UNIV MUNICH,KLINIKUM GROSSHADERN,FRAUENHEILKUNDE & GEBURTSHILFE KLIN & POLIKLIN,MUNICH,GERMANY
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [31] Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer
    Garcia-Mata, Jesus
    Garcia-Palomo, Andres
    Calvo, Lourdes
    Mel, Ramon
    Cruz, Juan Jesus
    Ramos, Manuel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (11): : 739 - 744
  • [32] Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer
    Jesús García-Mata
    Andrés García-Palomo
    Lourdes Calvo
    Ramón Mel
    Juan Jesús Cruz
    Manuel Ramos
    Clinical and Translational Oncology, 2008, 10 : 739 - 744
  • [33] High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study
    Cottu, PH
    Extra, JM
    Espie, M
    Marolleau, J
    de Roquancourt, A
    Makke, J
    Miclea, JM
    Laurence, V
    Mayeur, D
    Lerebours, F
    Cuvier, C
    Marty, M
    BRITISH JOURNAL OF CANCER, 2001, 85 (09) : 1240 - 1246
  • [34] A PROSPECTIVE RANDOMIZED TRIAL COMPARING EPIRUBICIN MONOCHEMOTHERAPY TO 2 FLUOROURACIL, CYCLOPHOSPHAMIDE, AND EPIRUBICIN REGIMENS DIFFERING IN EPIRUBICIN DOSE IN ADVANCED BREAST-CANCER PATIENTS
    BONNETERRE, J
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (02) : 305 - 312
  • [35] High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study
    P H Cottu
    J M Extra
    M Espie
    J P Marolleau
    A de Roquancourt
    J Makke
    J M Miclea
    V Laurence
    D Mayeur
    F Lerebours
    C Cuvier
    M Marty
    British Journal of Cancer, 2001, 85 : 1240 - 1246
  • [36] A phase I study of accelerated high dose epirubicin (HDE) and cisplatin with G-CSF support in patients with advanced non small cell lung cancer (NSCLC)
    Smit, EF
    Postmus, PE
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S31 - S31
  • [37] HIGH-DOSE CHEMOTHERAPY WITH HEMATOPOIETIC SUPPORT FOR BREAST-CANCER
    STEWARD, WP
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : S21 - S24
  • [38] A phase I/II study on dose-densification of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy with support of G-CSF in locally advanced or metastatic breast cancer
    Soetekouw, Patricia M.
    Laurens, Nicole G.
    Timmer-Bonte, Anja N.
    Smilde, Tineke J.
    Boetes, Carla
    van Leeuwen, Frank
    De Mulder, Pieter H.
    Beex, Louk V.
    Tjan-Heijnen, Vivianne C.
    ANNALS OF ONCOLOGY, 2006, 17 : 73 - 73
  • [39] MITOXANTRONE PLUS VINORELBINE WITH GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) SUPPORT IN ADVANCED BREAST-CANCER PATIENTS - A DOSE AND SCHEDULE FINDING STUDY
    FRASCI, G
    COMELLA, G
    COMELLA, P
    SALZANO, F
    CREMONE, L
    DELLAVOLPE, N
    IMBRIANI, A
    PERSICO, G
    BREAST CANCER RESEARCH AND TREATMENT, 1995, 35 (02) : 147 - 156
  • [40] Dose-dense (DD) two-weekly docetaxel/doxorubicin/cyclophosphamide (TAC) with G-CSF support compared to standard adjuvant TAC in breast cancer patients
    Latifzadeh, S. Z.
    Salimi, M.
    Naghnaeian, M.
    Entezari, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345